2-morpholin-4-ylacetic Acid;hydrochloride - 95%, high purity , CAS No.89531-58-8

  • ≥95%
Item Number
M137089
Grouped product items
SKUSizeAvailabilityPrice Qty
M137089-250mg
250mg
In stock
$9.90
M137089-1g
1g
In stock
$24.90
M137089-5g
5g
In stock
$80.90
M137089-25g
25g
In stock
$363.90
M137089-100g
100g
In stock
$1,308.90

Basic Description

Synonymsinsulin, semi-Lente | 4-Morpholineacetic acid, hydrochloride | R935788 | 2-morpholin-4-ylacetic acid hydrochloride | BCP10116 | CS-W001669 | 4-Morpholinylacetic acid HCl salt | J-515838 | F2130-0038 | 2-morpholinoacetic acid hydrochloride salt | SY032269
Specifications & Purity≥95%
Shipped InNormal
Product Description

Product Application:

4-Morpholineacetic acid hydrochloride is used as a pharmaceutical intermediate.

Associated Targets(non-human)

rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid488199546
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488199546
IUPAC Name 2-morpholin-4-ylacetic acid;hydrochloride
INCHI InChI=1S/C6H11NO3.ClH/c8-6(9)5-7-1-3-10-4-2-7;/h1-5H2,(H,8,9);1H
InChi Key ICGYBJNONRDZOP-UHFFFAOYSA-N
Canonical SMILES C1COCCN1CC(=O)O.Cl
Isomeric SMILES C1COCCN1CC(=O)O.Cl
PubChem CID 17750946
Molecular Weight 181.62

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
G1811089Certificate of AnalysisDec 19, 2023 M137089
K2124601Certificate of AnalysisSep 11, 2023 M137089
K2124602Certificate of AnalysisSep 11, 2023 M137089
K2124605Certificate of AnalysisSep 11, 2023 M137089
D23191012Certificate of AnalysisSep 29, 2021 M137089

Chemical and Physical Properties

SolubilityInsoluble in water.
Melt Point(°C)179 °C

Safety and Hazards(GHS)

Pictogram(s) GHS05,   GHS07
Signal Danger
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H318:Causes serious eye damage

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing.

P317:Get emergency medical help.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

Related Documents

Citations of This Product

1. Yang Zhou, Fan Tong, Weilong Gu, Siqin He, Xiaotong Yang, Jiamei Li, Yue-Dong Gao, Huile Gao.  (2022)  Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors.  Acta Pharmaceutica Sinica B,  12  (1416).  [PMID:35530138]

References

1. Yang Zhou, Fan Tong, Weilong Gu, Siqin He, Xiaotong Yang, Jiamei Li, Yue-Dong Gao, Huile Gao.  (2022)  Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors.  Acta Pharmaceutica Sinica B,  12  (1416).  [PMID:35530138]

Solution Calculators